Cargando…
Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL
BACKGROUND: Clinically relevant methods are not available that prioritize and validate potential therapeutic targets for individual tumors, from the vast amount of tumor descriptive expression data. METHODS: We established inducible transgene expression in clinically relevant patient-derived xenogra...
Autores principales: | Liu, Wen-Hsin, Mrozek-Gorska, Paulina, Wirth, Anna-Katharina, Herold, Tobias, Schwarzkopf, Larissa, Pich, Dagmar, Völse, Kerstin, Melo-Narváez, M. Camila, Carlet, Michela, Hammerschmidt, Wolfgang, Jeremias, Irmela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493381/ https://www.ncbi.nlm.nih.gov/pubmed/32944247 http://dx.doi.org/10.1186/s40364-020-00226-z |
Ejemplares similares
-
A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models
por: Liu, Wen-Hsin, et al.
Publicado: (2021) -
Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
por: Mrozek-Gorska, Paulina, et al.
Publicado: (2019) -
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
por: Pich, Dagmar, et al.
Publicado: (2019) -
Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation
por: Buschle, Alexander, et al.
Publicado: (2021) -
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
por: Bahrami, Ehsan, et al.
Publicado: (2023)